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Abstract 
A simple, single-masked gold interdigitated triple-microelectrodes biosensor is presented by taking 
the advantage of an effective self-assembled monolayer (SAM) using an amino-silanization technique 
for the early detection of a prostate cancer’s biomarker, the prostate-specific antigen (PSA). Unlike 
most interdigitated electrode biosensors, biorecognition happens in between the interdigitated 
electrodes, which enhances the sensitivity and limit of detection of the sensor. Using the Faradaic 
mode electrochemical impedance spectroscopy (EIS) technique to quantify the PSA antigen, the 
developed sensing platform demonstrates a logarithmic detection of PSA ranging from 0.5 ng/ml to 
5000 ng/ml, an estimated LOD down to 0.51 ng/ml in the serum, and a good sensor’s reproducibility. 
The sensor’s detection range covers the clinical threshold value at 4 ng/ml and the crucial diagnosis 
‘grey zone’ of 4-10 ng/ml of PSA in serum for an accurate cancer diagnosis. The selectivity test revealed 
an excellent discrimination of other competing proteins, with a recorded detection signals at 5 ng/ml 
PSA as high as 7-fold increase versus the human serum albumin (HSA) and 8-fold increase versus the 
human glandular kallikrein 2 (hK2). The stability test showed an acceptable stability of the aptasensor 
recorded at six (6) days before the detection signal started degrading below 10% of the peak detection 
value. The developed sensing scheme is proven to exhibit a great potential as a portable prostate 
cancer biosensor, also as a universal platform for bio-molecular sensing with the versatility to 
implement nanoparticles and other surface chemistry for various applications.  
Keywords 
 Aptasensor; impedance; interdigitated microelectrodes; prostate-specific antigen; self-assembled 
monolayer 
1.0 Introduction 
 The proposed sensing strategy is a prognosticative tool to predict the early developmental 
stage of PCa, which is an alternative to the current detection in practice that rely greatly on the 
conventional enzyme-linked immunosorbent assay (ELISA) and detects the concentration of 
prostate-specific antigen (PSA) marker. The high sensitivity and reliability of ELISA are undeniable; 
however, its requirement for labels, high complexity, labor required, cost and non-portable 
characteristics have forged the technological loophole that needs to be filled to better suit for 
the demanding point-of-care (PoC) applications. There is therefore a need for a simpler, cheaper, 
more reliable, robust and rapid technique to detect cancer biomarkers in blood. Eliminating labels 
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or tags can lead to a simpler, cheaper alternative to biomarkers detection, however it gives rise 
to non-specific interactions in complex samples that reduces the device’s performance. 
One promising technique that warrants the portability, high sensitivity and robustness of 
surface modification chemistries is the use of screen-printed interdigitated microelectrode. A 
typical interdigitated microelectrode is made of gold/titanium bilayers on either pristine silica 
glass or silicon dioxide (SiO2) substrate. This architecture allows for flexibility to modify the 
sensing surface either using thiol-gold electrode surface chemistry (Zhurauski et al., 2018)(Arya 
et al., 2018) or through silanization of hydroxyl (OH) group on the glass/SiO2 in between the 
microelectrodes gaps. This modification technique does not only allow for great flexibility in 
sensor’s integration with novel micro- or nano-structured materials, it also allows for highly 
sensitive electrochemical detection method to be implemented, specifically the electrochemical 
impedance spectroscopy (EIS)-based sensing. EIS-based detection has gained popularity in 
biosensing application due to its ability to measure the changes in impedance and capacitance 
on the electrodes surface upon target binding process across a wide range of target concentration 
(Wang et al., 2015). With proper equivalent circuit fitting, EIS has the flexibility to be utilized to 
measure the changes of charge transfer resistance (Rct) using Faradaic mode of detection (in the 
presence of redox probes), or to measure changes in capacitance, extracted from impedance data 
using non-Faradaic mode of measurement (without redox probes).  
Monoclonal antibody (mAb)-based therapeutics has come a long way in the past four decades 
since the introduction of the first production technique by Georges Kohler and Cesar Milstein in 
1975. As of May 2018, the Food and Drugs Administration (FDA) and the European Medicines 
Agency (EMA) have approved a total of 80 therapeutic mAb globally (Hongrong Cai, 2018). 
Despite the inherent features, their main disadvantages include the relatively high production 
cost, require a longer development time, sensitive to the temperature deviation, and unlike 
aptamers, the mAbs are only capable of detecting immunogenic targets. Whilst mAbs are the 
epitome of biomolecular detection, the application of aptamers (aptasensors) has been 
demonstrated to yield a comparable sensitivity, specificity and affinity to that of mAbs (Gopinath, 
2011; Ibau et al., 2017; Savory et al., 2010). Other appealing properties of aptamers over mAbs 
include smaller sizes (6 – 40 kDa vs. ~150 kDa for mAbs), cost-effective due to high-throughput 
in-vitro selection technology (SELEX) generation technique, and customizable recognition site 
with a high predilection to the target molecules. Currently, ‘Macugen’ is the only therapeutic 
aptamer approved by the FDA for clinical use to treat age-related macular degeneration (AMD) 
of the retina, however several others are in approval stage (Stein and Castanotto, 2017). Unlike 
the antibodies which rely on the immunogenic response, aptamers hold the unprecedented 
potential for a greater flexibility to ‘sense’ for a wider range of target molecules (Bagheri et al., 
2018; Feng et al., 2014; Seok Kim et al., 2016).    
We here report the findings on the development of highly sensitive and specific gold 
interdigitated triple microelectrodes-based sensor to detect PSA using an anti-PSA aptamer. The 
in-house fabricated sensing microelectrodes were chemically modified through amino-
silanization on the SiO2 gap between the patterned gold triple microelectrodes. This technique 
allows for sensitive detection and estimation of different concentrations of PSA antigen by 
measuring the changing surface resistance on the device, which translates to the changes in Rct 
and total impedance of the EIS measurement system. The use of interdigitated microelectrode 
enables for a greater flexibility in the sensing surface modifications and the use of robust, highly 
sensitive PSA target detection schemes, e.g. measurement in (i) the changes of surface resistance 
and (ii) the capacitive effects in the EIS setup. The microelectrode arrays increase the effective 
sensing area that enables for greater DNA-aptamer probe loading and PSA binding event. Further 
increase in the effective sensing surface area-to-volume ratio is achievable through the 
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deposition of nanoparticles and novel nanostructured materials, i.e. molybdenum disulfide 
(Dalila R et al., 2019) in between the microelectrode gaps. Moreover, the authors demonstrate 
the device architecture does not only exhibit an exceptional detection performance, but also to 
benefit from the inherent portability feature and the high-volume fabrication capability of the 
device.     
 
2.0 Experimental 
2.1 Materials and reagents 
 A 32-nucleotide carboxyl-terminated anti-PSA DNA aptamer (5’-COOH-C6-TTT TTA ATT 
AAA GCT CGC CAT CAA ATA GCT TT-’3) was procured from Integrated DNA Technologies 
(IDT, Singapore). The sequence was modified from the work reported in (Savory et al., 
2010), in which a genetic algorithm (GA) was applied to post-SELEX screening of the 
oligonucleotide, and resulted in 48-fold higher binding affinity compared to those 
obtained from SELEX alone, and a dissociation constant (KD) in tens of nM. Prostate-
specific antigen (PSA) was procured from Fitzgerald (MA, USA), and diluted into different 
testing concentrations in Buffer A, which consists of 100 mM PBS (pH 7.4). 3-
Aminopropyltrimethoxysilane (APTES), 1-ethyl-3-dimethylaminopropylcarbodiimide 
hydrochloride (EDC), N-hydroxysuccinimide (NHS), potassium buffer saline tablets (pH 
7.4), potassium hexacyanoferrate (III), and potassium hexacyanoferrate (II) were all 
purchased from Sigma Aldrich (Malaysia). StartingBlock phosphate buffer saline-Tween 
20 (SBPBS-T20), as termed Blocker A in this report was procured from Fisher Scientific 
(UK). All other reagents were of analytical grade, and all aqueous solutions were prepared 
using 18.2 MΩ ultra-pure Milli-Q water, and further filtered through Pyrogard® 0.22 μm 
pore filter (Millipore, MA, USA). 
2.2 Measurement and apparatus 
 The morphology of the sensing surface was characterized via atomic force microscopy 
(AFM) in ambient tapping mode using SPA400-SPI4000 AFM (Seiko Instruments Inc., 
Japan) in conjunction with Nano Navi SPA400 software for imaging and analyses. The 
morphological profiles were imaged using 10 nm in diameter SI-DF20 cantilever (Seiko 
Instruments Inc., Japan), at spring constant of 11 N/m and resonance frequency of 122 
kHz. The water contact angle was measured using an in-house built optical angle 
measurement system (Miodek et al., 2015). The measurement was carried out by 
dispensing 30 μl of water droplet onto the electrode surface, and subsequently, Nikon 
COOLPIX P520 camera with 18.1 megapixels sensor was used to capture the contact 
angles at a fixed focal length of 37 mm. OnScreenProtractor version 0.5 (Iconico) was 
used to measure the contact angle. 
 An X-ray photoelectron spectroscopy (XPS) model XPS XSAM-HS (Kratos, UK) with 
focused monochromatic Mg Kα X-ray source (run at 120 W) was used to characterize the 
surface elemental analysis to validate sensing surface functionalization. The chamber 
pressure was set at 5 x 10-8 torr for each sample analysis, in which was recorded in the 
energy range between 10 to 1100 eV, where the pass energy and step size were set at 
150 and 1 eV per step. The peak analysis was performed using CasaXPS processing 
software version 2.3.16, and references for peaks analysis were made from the XPS 
handbook and the National Institute of Standard and Technology (NIST) XPS online 
database.  Electrochemically, the sensors were characterized in Faradaic mode of 
detection using a μAUTOLAB III/FRA2 potentiostat (Metrohm Autolab, Netherlands). 
Validation of successful sensing surface functionalization and probe binding was carried 
out via cyclic voltammetry (CV) in a three-electrode configuration as reported in (Arya et 
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al., 2018). CV measurement was performed in Buffer B, which consists of 50 μl of 100 
mM PBS (pH 7.4) containing 2 mM [Fe(CN)6]3-/4- redox couple at scanning potential of -
0.6 V to 0.6 V. Detection and estimation of binding event at different concentration of 
PSA onto aptamer were done via Faradaic mode EIS. The impedance spectrum was 
measured using gold as counter (2 mm width) and pseudo-reference electrodes at an 
open circuit potential (OCP) in the frequency range of 100 kHz to 0.5 Hz, with a 100 mV 
amplitude in Buffer C, consists of 50μl of 100 mM phosphate buffered saline (PBS) buffer 
(pH 7.4) containing 5 mM [Fe(CN)6]4- (ferrocyanide) and 5 mM [Fe(CN)6]3- (ferricyanide) 
redox couple on the sensing surface. 
2.3 Microelectrode preparation and functionalization 
2.3.1 Fabrication of gold interdigitated electrodes 
 The interdigitated electrodes were fabricated using a conventional 
micro-fabrication technique, with a simple, single-masked photolithography 
process for structural patterning and development of the device. Briefly, a 
bilayer negative photoresist (NR7-3000PY/NR71-3000P Futurrex, USA) was 
spin-coated onto the silicon/silicon dioxide substrate and the chrome mask 
with interdigital fingers of 10 μm in width and 3500 μm in length, with spacing 
in between fingers at 10 μm that spread over 6000 μm was transferred onto 
the resists. Subsequently, Ti/Au bilayers (~20 nm/~250 nm) were evaporated 
successively onto the developed photoresists, and then the bi-layer 
photoresists were ‘lifted-off’, leaving behind the patterned gold interdigitated 
electrodes on the substrate.  
2.3.2 Sensing surface modifications 
 Prior to surface functionalization procedures, a batch of three gold 
interdigitated electrodes were cleaned thoroughly by sonication in acetone, 
isopropanol (IPA), and Milli-Q water, followed by nitrogen blow dry, and then 
30 min of ultraviolet (UV)-ozone treatment in ProCleaner (Bio-Force 
Nanoscience, USA). A self-assembled monolayer (SAM) layer was obtained 
through amino-silanization of the hydroxyl group onto the SiO2 gap in 
between gold interdigitated as reported in (Zhu et al., 2012) with slight 
modifications. Briefly, the cleaned devices were immediately placed in a 
desiccator, followed by incubation with 50 μl of 2% APTES (pre-diluted to 
working concentration in anhydrous toluene) for 120 min at 70°C. The 
unreacted APTES was then rinsed with toluene (2x), absolute ethanol (2x), 
and Milli-Q water (2x), and followed by drying in a muffle furnace at 110°C for 
15 min. The silanized devices were hydrolytically stabilized overnight in Milli-
Q water at 40°C, subsequently rinsed with Milli-Q water and dried in a muffle 
furnace at 110°C for 15 min. Before use, the carboxyl-terminated anti-PSA 
DNA aptamer was first heated to 90°C for 2 min to unfold its structure and 
cooled down to room temperature (RT). Next, 990 μl of 2 µM DNA aptamer, 
diluted to working concentration in Buffer A was incubated into the mixed 
solution (1:1 v/v) of 10 μl 400 mM EDC/100 mM NHS cross-linker for 30 min 
to activate the carboxyl group on the aptamer. Then, 50 μl of 2 µM EDC-
activated DNA aptamer was incubated onto the APTES-functionalized 
electrodes for 60 min to allow for DNA aptamer binding on the SAM surface. 
To avoid deposition of the negatively charged DNA aptamer onto the gold 
electrodes through electrostatic interaction which may lead to high 
background noise during measurements, the electrode was biased with a 
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small potential of -75 mV to repel the aptamer from the gold electrode. 
Thereafter, the unreacted DNA aptamer was rinsed with a copious amount of 
Buffer A, and subsequently, the unbound active sites were blocked using 
undiluted Blocker A for 15 min, then rinsed off the extra solution on the 
electrodes surface. Otherwise mentioned, all the steps were performed at RT. 
The functionalized interdigitated electrodes were stored in 4°C fridge until 
further use. Fig. 1 shows the overall process for micro-fabrication and surface 
modification on the transducer surface of the interdigitated microelectrodes. 
       
 
Fig. 1A(i-iv). The conventional photolithography process steps to fabricate the gold interdigitated 
microelectrode. Fig. 1B. The Faradaic EIS detection scheme for PSA target on sensing surface. Fig. 1C. 
Representation of surface modification techniques on the electrode surface for the detection of PSA 
protein. Images drawn not according to the actual dimensions. 
3.0 Results and discussion 
3.1 X-ray photoelectron spectroscopy (XPS) characterization on sensing surface 
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 XPS technique was used to quantify the elemental composition and chemical state on 
the functionalized sensing surface (scan depth ~5-10 nm), thus validated the presence of 
the desired functional groups that are responsible for the binding of targeted linking 
chemistries. All spectra peaks were calibrated according to the inherent ‘adventitious’ 
carbon, C 1s peak at a binding energy (BE) of 284.8 eV due to the air-exposed samples 
which correspond to the presence of C-C hydrocarbon bonds. The XPS survey spectra for 
the sensing electrode’s modification steps are shown in Fig. 2A(i). 
 Fig. 2B(i) shows the Si 2p narrow spectra which revealed three distinct peaks at BE of 
99.8 eV showing the presence of SiO2 on the pristine electrode surface. Upon treatment 
using APTES, the presence of peaks at 101.7 eV and 102.2 eV validate the formation of 
silane (SiH4) group through the silanization of APTES with the hydroxyl group on the SiO2. 
These two distinct peaks are corresponding to the type of amino-silane formation on the 
pristine substrate, i.e. single monolayer at 101.7 eV and multilayer formation at 102.2 eV. 
These self-assembled layers were formed when the reactive methoxy (OCH3) head groups 
of APTES was hydrolyzed to silanol (Si-OH), subsequently tethered the silane molecules 
onto SiO2 through condensation process (Dietrich et al., 2016), as shown in Fig. 2A(ii). The 
C 1s spectra shown in Figure 2B(ii) validate all the functional groups present in APTES 
functionalized surface with good agreement with works reported in (Cao et al., 2009; 
Evans, 1997), i.e. alkyl carbon, C-C (284.8 eV), carbon atoms with single bond to oxygen 
or nitrogen, C-N/C-O (286.3 eV) and an amide, O=C-N (288.1 eV). Though, these peaks 
could be resulted from the inherent hydrocarbon contamination due to the air-exposed 
samples (Acres et al., 2012), the significant increment in the peak intensity before and 
after APTES modification step further validate the presence of functional moieties from 
APTES functionalization. The increment in O=C-N (amide) peak at 288.1 eV with post-
aptamer immobilization step confirmed the successful binding of EDC-activated anti-PSA 
aptamer onto the silanized SiO2 surface. Another validation on successful aptamer 
immobilization was shown in Fig. 2B(iv), showing two distinct P 2p peaks at 132.5 eV and 
133.6 eV that confirm the presence of the conjugated DNA aptamer’s sugar-phosphate 
backbone on the sensing surface (Chung et al., 2018; Wang et al., 2018). Fig. 2B(iii) shows 
the N 1s peaks at BE of 400.1 eV and 401.9 eV further validated the presence of 
unbounded free amine (NH2) group and hydrogen-bound amine (H-NH2) group, the 
characteristics of successful surface functionalized with APTES (Acres et al., 2012; 
Vandenberg et al., 1991). 
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Fig. 2. XPS spectra analysis of surface functionalization on the sensing surface. Fig. 2A(i). An overlay of 
XPS survey spectra for each electrode modification step. Fig. 2A(ii). APTES silanization process with a 
hydroxyl group on SiO2 substrate. Fig. 2B(i-iv). High-resolution narrow peaks of Si 2p, C 1s, N 1s and P 
2p with respect to the binding energy (BE). 
3.2 Cyclic voltammetry (CV), atomic force microscopy (AFM) morphology and hydrophobicity 
study via water contact angle measurement 
 Besides XPS quantification, CV scan was performed in Buffer B to further validate the 
aptamer-probe immobilization on the sensing surface. The changes in the working 
electrode, WE peak current (μA) over the range of cycling potential at -0.6 V to 0.6 V were 
recorded, as shown in Fig. 3A. Prior to any modifications, the pristine electrode shown in 
Fig. 3A(i) recorded a low surface resistivity with peak current at 305.3 μA, which shows a 
clean, conductive electrode. In Fig. 3A(ii), the modification with APTES has drastically 
reduced the peak current from 305.3 μA to 211.4 μA due to an increase in surface 
resistance due to the successful formation of the SAM layer in between the interdigitated 
gaps due to the APTES silanization. The peak current was further reduced to 168.7 μA 
upon immobilization with EDC-activated anti-PSA aptamer probe, as shown in Fig. 3A(iii). 
Furthermore, after the sensing surface was blocked with Blocker A protein, the peak 
current was further reduced to 155.3 μA. This reduction confirms the full coverage of the 
free surface by the blocking proteins. 
Fig. 3B shows the morphological study on the modified electrode’s surface, (i) APTES 
– EDC/NHS coupling, and (ii) anti-PSA aptamer bound surface using AFM characterization 
in tapping mode. The images showed drastic changes in the overall surface roughness 
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after the aptamer immobilization. The mean surface roughness (Ra) and maximum 
roughness (Rmax) had decreased from 1.23, 9.37 down to 0.98, 5.66 respectively, which 
suggested successful binding of the aptamer on the electrode’s surface. Furthermore, 
water contact angle measurements were conducted to further validate the binding of the 
aptamer. As shown in Fig. 3C(i), the promotion of OH functional group after the UV-ozone 
treatment has rendered the sensing surface hydrophilic. Besides promoting the OH for 
silane tethering, UV-ozone treatment is an effective electrode’s cleaning technique after 
the sonication in acetone, IPA and Milli-Q water. APTES silanization on the substrate 
introduced alkyl chains and amino groups, an evident in the increased in water contact 
angle from hydrophilic surface to 73.32 ± 2° as shown in Fig. 3C(ii), which is comparable 
to the finding reported in (Cao et al., 2009). In Fig. 3C(iii), upon DNA aptamer binding 
event the contact angle was further reduced to 61.45 ± 2°, confirming the successful 
binding of anti-PSA aptamer onto the sensing surface.  
 
Fig. 3. Electrical and optical characterizations of the sensing surface’s functionalization process using 
(A) CV measurement in Buffer B, (B) atomic force microscopy (AFM) characterization, and (C) water 
contact angle measurement techniques. 
3.3 Quantification of PSA detection via impedimetric measurement in Faradaic EIS mode 
 The interaction between immobilized anti-PSA aptamer against different 
concentrations of PSA was carried out by incubating 50 µl of the diluted antigen (pre-
diluted to working concentration in Buffer A) onto the sensing surface in a batch of three 
devices for 60 min at 37°C. The devices were then rinsed with a copious amount of Buffer 
A, subsequently, incubated in 50 µl of Buffer C for 10 min to stabilize the SAM layer. The 
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impedance spectrum was then measured in 50 µl Buffer C at an open circuit potential 
(OCP) in the frequency range of 100 kHz to 0.5 Hz, with a 100 mV amplitude perturbation. 
 The detection scheme was carried out by measuring the changes in the charge 
transfer resistance, Rct (represented by Nyquist plot) and the total impedance, Z versus 
frequency (represented by Bode plot) of the electrochemical system due to the PSA – 
aptamer binding onto the modified interfacial layer, i.e. the microelectrode gaps that 
caused the disruption to the equilibrium potential of the [Fe(CN)6]4-/3- redox couple. In 
this measurement, the change in the Rct values correspond to the alteration of the  
modified interfacial layer on the microelectrode gaps causing the changes in the intensity 
of electrons transfer from the redox species onto the microelectrode surface as depicted 
in Fig. 1B, in which the magnitude of the changes is according to the concentration of PSA 
bound onto the aptamer (Park et al., 2018). Moreover, the gold microelectrode surface 
was effectively blocked using the Blocker A (refer to Fig. 1B). Besides avoiding the non-
specific binding, the step ensures a consistent charge transfer between the redox 
potential and the gold electrode surface, hence any modification onto the interfacial 
layer, such as the biomolecular binding event would result in a very specific, highly 
sensitive change in the magnitude of Rct values. Moreover, the modification of the 
interfacial layer was performed in between the microelectrode’s gaps which enhances 
the device’s sensitivity in detecting slight changes in the resistance of the charge transfer 
in the redox potential due to the target molecule’s binding. 
 Two types of detection data were reported in the findings, firstly the Nyquist plot as 
shown in Fig. 5A(i) and Bode plot in Fig. 5A(ii). The Nyquist plot shows the -Z” vs. Z’ 
relationship upon interaction with different PSA concentrations from 0.5 ng/ml down to 
5000 ng/ml. Prior to the sensor’s surface modification, the pristine electrode surface 
exhibits the lowest Rct value of 153 Ω due to the absence of the resistive APTES SAM layer 
on the electrode, as shown in the inset (b) of Fig. 5A(i). The successful SAM assembly, 
aptamer immobilization and Blocker A blocking protein resulted in a drastic increased in 
Rct recorded at 5.804 kΩ (mean Rct value measured across a batch of three sensors, n=3). 
The successful binding of PSA target is validated via the reduction of Rct values which took 
place in the presence of PSA antigen, and these changes occurred only at the Rct value 
above that of the ‘Aptasensor’ baseline value. Inset (a) of Fig. 5A(i) shows the schematic 
diagram of the equivalent Randles circuit used for electrochemical fitting, where Rs is the 
resistance of electrolyte solution, Q is a constant phase element (CPE) and Zw is Warburg 
impedance. The Bode plot in Fig. 5A(ii) exhibits a similar trend as the Nyquist’s for 
different concentrations of PSA. This is due to the higher density of bound PSA molecules 
onto the aptamer increases the total Z values on the sensing surface. The sensors 
responded to these changing effects at a frequency below 104 Hz, as evident from the 
increasing impedance values against the decreasing frequency. The magnitude of slope 
from the impedance curve directly corresponds to the abundance of ions or molecules 
adsorbed on the sensing surface (Madianos et al., 2018), i.e. the binding of PSA molecules 
on the aptamers. For the frequency range above 104 Hz, the constant impedance value 
(the horizontal line from frequency 104 to 105 Hz) represents the measured fixed value of 
Rs, irrespective to the modification on the sensing surface or molecular binding event.    
 The linearity response for the increase of Rct and total Z against the increasing PSA 
concentrations are depicted in Fig. 5B(i) and Fig. 5B(ii), respectively. Fig. 5B(i) shows the 
calibration curve with respect to the Nyquist response, plotted from mean changes in Rct 
(kΩ) from the ‘Aptasensor’ baseline values (without the introduction of PSA) at 2.0 Hz 
versus the logarithmic scale of PSA concentration in PBS (ng/ml). The calibration curve 
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shows the capability of the sensors for a linear detection of PSA antigen in the range of 
0.5 ng/ml down to 5000 ng/ml, following the linear equation Rct (kΩ) = 0.659 [kΩ] + 
0.673 log10 [PSA] (ng/ml). The sensors exhibit a sensitivity of 0.673 kΩ/log10 ([PSA] ng/ml) 
and a correlation coefficient (R2) of 0.978. The limit of detection (LOD) and limit of 
quantification (LOQ) were estimated as 0.413 ng/ml and 10.078 ng/ml, respectively, using 
the linear regression analyses (Shrivastava and Gupta, 2011). The estimation of LOD and 
LOQ were expressed using the formulae: 
𝐿𝑂𝐷 =
3𝛼
𝑏
 , 
𝐿𝑂𝑄 =
10𝛼
𝑏
 , 
where α is the standard deviation of the sensor’s response, estimated from y-residuals of 
the calibration curve and b is the sensitivity of the sensors computed from the slope of 
the calibration curve. Meanwhile Fig. 5B(ii) shows the calibration curve with respect to 
the Bode response, plotted from the mean changes in total Z values (kΩ) from the 
baseline values at 2.0 Hz versus the logarithmic scale of PSA concentration in PBS (ng/ml). 
This Bode response-based calibration curve reveals a linear detection in the range of 0.5 
ng/ml to 5000 ng/ml following a linear equation Z (kΩ) = 2.139 [kΩ] + 2.710 log10 [PSA] 
(ng/ml), a sensitivity of 2.710 kΩ/log10 ([PSA] ng/ml), and R2 of 0.993. Interestingly, the 
response shows a slightly lower LOD and LOQ, estimated at 0.377 ng/ml and 2.686 ng/ml 
respectively. This reduction in the estimation of LOD and LOQ is due to greater linearity 
response from the Bode data, hence resulting in a higher confidence level in estimating 
both limits. 
 Table 1 shows the comparison in sensing performance of the reported work to other 
assays. It is shown that the developed sensor exhibits a comparable linear detection 
range to other reported assays. In this work, the authors demonstrated the use of a 
simpler and cost-effective approach to obtain a linear and acceptable detection limit 
without the use of graphene derivative materials which bare extra development cost. The 
reported approach is applicable for the application of prostate cancer’s detection which 
has a clinical cut-off value of 4 ng/ml.  
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Fig. 5. EIS responses of developed sensing devices to detect different concentrations of PSA antigen, 
measured in Buffer C. A(i). The -Z” vs. Z’ ‘Nyquist plot’ with an inset (a) showing the equivalent Randle’s 
circuit. A(ii). The total Z vs. frequency ‘Bode plot’. Fig. B. The calibration curve with respect to (i) 
Nyquist plot and (ii) Bode plot. 
3.4 Demonstration of PSA estimation in physiological serum 
 The feasibility of the developed sensors for clinical applications was tested in 
undiluted human serum spiked with concentrations of PSA ranging from 0.5 ng/ml to 
5000 ng/ml. The setup evaluates the ability for the sensors to detect the PSA molecule, 
while discriminating other inherent proteins in the serum, demonstrating high specificity 
of the sensors. The Faradaic mode EIS technique was implemented to detect PSA in the 
serum, meanwhile with Bode plots used to illustrate the detection results due to its 
greater linearity as demonstrated for detecting PSA in PBS solution. Fig. 6 shows the PSA 
sensing performance in undiluted serum. Prior to detecting the diluted range of PSA, the 
assay was first subjected for the dose-response test with concentrated 1 µg/ml of PSA to 
first evaluate as if the sensors respond to the concentrated dose of the analyte.  
 Fig. 6(i) shows the dose-response before and after the introduction of the target 
antigen. At 2.0 Hz, the sensors demonstrated the highest percentage increase in total Z 
(kΩ) by 237.82% and -phase (°) change by 143.99% after the binding event. Hence, 
subsequent analyses were carried out at the sensor’s highest response at 2.0 Hz. Fig. 6(ii) 
depicts the Bode plot for the detection of PSA in undiluted serum. The sensors exhibit a 
similar response towards the different concentrations of PSA as compared to the 
identical assay in PBS. However, a reduction in the overall magnitude of total Z (kΩ) was 
observed for detecting each of PSA dilutions. This could be due to the increase in the total 
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Z of the electrolyte due to the presence of other proteins in the undiluted human serum. 
However, the sensors were able to distinguish in sensing PSA antigen from other proteins 
as evident from an increasing trend in total Z values against the increasing concentration 
of PSA in the serum. Similar to the assay in PBS, this detection assay’s response to changes 
in PSA concentrations within the frequency range <104 Hz. 
 The calibration curve in Fig. 6(iii) validates a linear detection of PSA in the undiluted 
human serum with a linear range of 0.5 ng/ml down to 5000 ng/ml following a linear 
equation Z (kΩ) = 0.907 [kΩ] + 1.212 log10 [PSA] (ng/ml), a sensitivity of 1.212 kΩ/log10 
([PSA] ng/ml), and R2 of 0.989. As compared to the assay tested in PBS, in undiluted serum, 
it was observed that both estimated LOD and LOQ have increased to 0.510 ng/ml and 
5.903 ng/ml respectively. These increases in LOD, LOQ and lower sensitivity of detection 
at 1.212 kΩ/log10 [PSA](ng/ml) in serum as compared to PBS were caused by the greater 
background noise due to higher abundance of competing proteins against the aptamer 
in the serum. Nonetheless, the sensors demonstrate a great degree in discriminating the 
non-specific proteins in the serum, hence proving the applicability of the developed 
sensors as a feasible approach for estimating the abundance of PSA antigens in clinical 
settings. 
 
Fig.6. The feasibility study of EIS responses for evaluating sensor’s specificity, tested against different 
concentrations of PSA in undiluted human serum. (i). Dose-response for changes in total Z and phase 
data versus frequency before and after PSA binding at 1 µg/ml. (ii). Bode plot for detection of different 
concentrations of PSA. (iii). Calibration curve showing linear detection of PSA concentration in 
undiluted human serum.  
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3.5 Reproducibility, selectivity and stability studies of the developed sensor 
 The sensing performance of the developed sensing architecture was tested to validate 
the reliability of the detection results. Fig. 7(i) shows the bar graph with SD error bars of 
a batch of three tested sensors, with relative standard deviation (R.S.D) for n=3 in 
detecting each diluted PSA concentrations of 0.5 ng/ml – 5000 ng/ml. The data show a 
good reproducibility with highest R.S.D of 4.24% (n=3). Another test was conducted to 
study the selectivity of the sensors in sensing PSA versus human serum albumin (HSA) 
and human glandular kallikrein 2 (hK2) as negative control, tested at selected 
concentrations of 5 ng/ml and 50 ng/ml. hK2 is another prostate-specific kallikrein 
marker which has 80% DNA sequence homology to PSA. Successful discrimination in 
detecting PSA target against hK2 therefore demonstrate a high selectivity performance 
of the sensor. Fig. 7(ii) shows an excellent selectivity with a recorded detection of PSA 
signal of 9-fold increased versus HSA and 6-fold increased versus hK2 at tested 
concentration of 5 ng/ml. At 50 ng/ml, the PSA detection signal recorded a 7-fold increase 
versus HSA and 8-fold increase versus hK2, which demonstrate an excellent selectivity of 
the device. Fig. 7(iii) shows the stability study for the sensor for each of the surface 
modification step. The inset figure depicts the measured relative Z values degradation of 
the Aptasensor bound to the 5 ng/ml PSA target, in which the Aptasensor were stored 
for 3 weeks and a batch of sensors (n=3) were tested for binding stability with PSA target 
at every three consecutive days. The aptasensors were stored in 100 mM PBS solution 
(pH 7.4) at RT throughout the duration. In this study, the measured Z values which had 
degraded more than 10% of the peak signal were considered losing its stability. From the 
figure, the aptasensor retained its stability for six (6) days before the Z values plummeted 
below 10% from the peak value. This degradation in Z value could be hypothesized due 
to the DNA aptamer folding event and the protein denaturation tested at RT which 
altered the electrical characteristics on the sensing surface over the prolonged tested 
duration. Another probable contributing factor is the unavailability of strong carboxyl 
(COOH)-modified aptamer 5’ end due to the nature of the aptamer secondary structure. 
This limitation may hinder the prolonged aptamer attachment after the tested 6 days 
period. Due to the same reason, the APTES modified surface may not hold the aptamer 
after the stated stability period of 6 days. 
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Fig. 7. Sensor’s performances. (i). Reproducibility data of the detection assay with calculated R.S.D for 
n=3. (ii). Selectivity data for the sensors in discriminating undiluted HSA against PSA and hK2. (iii). 
Stability performance of the sensor. 
Table 1 
Performance comparison of the developed sensor 
Scheme Assay Probe immob. strategy Sample 
volume 
Detection range LOD Ref. 
GCE CV/EIS GCE/SP-rGO-GA/anti-PSA 
mAb 
N/A 80 ng/ml – 0.1 
ng/ml 
53.00 pg/ml (Wang et al., 
2015) 
GCE DPV/EIS GCE/rGO-chitosan/GA/TH-
anti-PSA mAb-TH 
10 μl 90 ng/ml – 0.1 
pg/ml 
10.00 fg/ml (Kavosi et al., 
2015) 
GCE Ampero GCE/GO-PDDA-
chitosan/peptide-IL 
80 μl 100 ng/ml – 1 
fg/ml 
1.00 fg/ml (Tang et al., 
2017) 
IDE EIS Cr-Au/Cys-SAM/EDC-
NHS/anti-PSA mAb 
N/A 100 ng/ml – 1 
pg/ml 
1.00 pg/ml (Arya and 
Bhansali, 2012) 
Au disc CV/EIS Au/L-cysteine-SAM/EDC-
NHS/anti-PSA mAb 
N/A 30 ng/ml – 1 
ng/ml 
0.03 ng/ml (Spain et al., 
2016) 
Carbon 
SPE 
Ampero
/CV 
SPE/MPs-anti-PSA scAb N/A 10 ng/ml – 1 
ng/ml 
0.50 ng/ml (Zapatero-
Rodríguez et 
al., 2018) 
Au IDE CV/EIS IDE/APTES/EDC-NHS/anti-PSA 
aptamer 
50 μl 5000 ng/ml – 0.5 
ng/ml 
0.51 ng/ml 
(in serum) 
This work 
Note: GCE: Glassy Carbon Electrode, IDE: Interdigitated electrode, MGIDEA: Micro-gapped Interdigitated Electrode Array, 
SPE: Screen-printed Electrode, SP: silk peptide, rGO: reduced graphene oxide, GA: glutaraldehyde, TH: thionine, PDDA: Poly 
(dimethyldiallyammonium chloride), Cr: chromium, Cys-SAM: cysteamine SAM, scAb: recombinant single-chain antibody 
 
4.0 Conclusion 
 Prostate cancer is responsible for 29% of all cancer’s cases with a record of 13% deaths 
worldwide. Its ‘silent’ nature means the symptoms are hardly detectable, therefore when the 
symptoms prevail, it already signifies the metastasized form of cancer. In response, this paper 
reports the development work on an Aptasensor-based PSA biosensing assay for early cancer 
prognosis. The in-house fabricated gold interdigitated triple microelectrodes sensors yield an 
excellent sensitivity of 2.710 kΩ/log10 ([PSA] ng/ml) and LOD down to 0.38 ng/ml, besides a linear 
detection ranging from 0.5 ng/ml to 5000 ng/ml, covering the clinical PSA threshold value of 4 
ng/ml for occurrence of prostate cancer, and also the crucial ‘grey zone’ of 4 ng/ml to 10 ng/ml 
which usually leads to false diagnoses. Furthermore, the limit of detection reported in this paper 
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is among the lowest for detection of PSA. The sensors exhibited good reproducibility, as evident 
from the low R.S.D at 4.24% (n=3), hence proving the high sensitivity, great selectivity for 
detecting PSA with more than 7-fold increase in detection signal versus HSA and more than 6-fold 
increase versus hK2. The reported assay demonstrates the analytical reliability with an acceptable 
detection stability of six (6) days for the aptasensor. The principal benefit of the developed 
sensors is the architecture was designed to allow for greater flexibility of surface functionalization 
techniques and integration of various nanoparticles or nanostructures to enhance the sensitivity 
and detection limits. 
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